"programmed cell death ligand 2" trang 4 - tải miễn phí từ tailieunhanh
Prediction of patients with a tumor proportion score > 50% who do not respond to first-line monotherapy with pembrolizumab

Prediction of patients with a tumor proportion score > 50% who do not respond to first-line monotherapy with pembrolizumab
6    31    1
The prognostic value of PKM2 and its correlation with tumour cell PD-L1 in lung adenocarcinoma

The prognostic value of PKM2 and its correlation with tumour cell PD-L1 in lung adenocarcinoma
12    63    1
‘DURVIT’: A phase-I trial of single low-dose durvalumab (Medi4736) IntraTumourally injected in cervical cancer: Safety, toxicity and effect on the primary tumour and lymph node microenvironment

‘DURVIT’: A phase-I trial of single low-dose durvalumab (Medi4736) IntraTumourally injected in cervical cancer: Safety, toxicity and effect on the primary tumour and lymph node microenvironment
8    71    1
Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells

Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells
13    61    1
Identification and phylogenetic analyses of VASt, an uncharacterized protein domain associated with lipid-binding domains in Eukaryotes

Identification and phylogenetic analyses of VASt, an uncharacterized protein domain associated with lipid-binding domains in Eukaryotes
12    37    1
Molecular dynamics of the immune checkpoint programmed cell death protein I, PD-1: Conformational changes of the BCloop upon binding of the ligand PD-L1 and the monoclonal antibody nivolumab

Molecular dynamics of the immune checkpoint programmed cell death protein I, PD-1: Conformational changes of the BCloop upon binding of the ligand PD-L1 and the monoclonal antibody nivolumab
12    22    1
Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: The multicentre prospective Safe Stop trial

Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: The multicentre prospective Safe Stop trial
9    42    1
Pembrolizumab with or without enzalutamide in selected populations of men with previously untreated metastatic castration-resistant prostate cancer harbouring programmed cell death ligand1 staining: A retrospective study

Pembrolizumab with or without enzalutamide in selected populations of men with previously untreated metastatic castration-resistant prostate cancer harbouring programmed cell death ligand1 staining: A retrospective study
11    27    1
Genome-wide identification, evolution and expression analysis of the aspartic protease gene family during rapid growth of moso bamboo (Phyllostachys edulis) shoots

Genome-wide identification, evolution and expression analysis of the aspartic protease gene family during rapid growth of moso bamboo (Phyllostachys edulis) shoots
20    54    1
Nanoparticle albumin-bound paclitaxel and PD-1 inhibitor (sintilimab) combination therapy for soft tissue sarcoma: A retrospective study

Nanoparticle albumin-bound paclitaxel and PD-1 inhibitor (sintilimab) combination therapy for soft tissue sarcoma: A retrospective study
9    55    3
Safety, activity, and pharmacokinetics of camrelizumab in advanced Asian melanoma patients: A phase I study

Safety, activity, and pharmacokinetics of camrelizumab in advanced Asian melanoma patients: A phase I study
10    26    1
Association of a novel 27-gene immuno-oncology assay with efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer

Association of a novel 27-gene immuno-oncology assay with efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer
10    16    1
Molecular mapping of a novel lesion mimic gene (lm4) associated with enhanced resistance to stripe rust in bread wheat

Molecular mapping of a novel lesion mimic gene (lm4) associated with enhanced resistance to stripe rust in bread wheat
9    17    1
Bioinformatic analysis of PD-1 checkpoint blockade response in infuenza infection

Bioinformatic analysis of PD-1 checkpoint blockade response in infuenza infection
13    19    1
Steven-Johnson syndrome: A rare but serious adverse event of nivolumab use in a patient with metastatic gastric adenocarcinoma

Steven-Johnson syndrome: A rare but serious adverse event of nivolumab use in a patient with metastatic gastric adenocarcinoma
7    6    1
Ebook Xylem: Methods and protocols

Ebook Xylem: Methods and protocols
257    4    1
Ebook Microbial stress tolerance for biofuels: Systems biology

Ebook Microbial stress tolerance for biofuels: Systems biology
311    10    1
Target metabolite and gene transcription profiling during the development of superficial scald in apple (Malus x domestica Borkh)

Target metabolite and gene transcription profiling during the development of superficial scald in apple (Malus x domestica Borkh)
13    103    0
Over-expression of poplar NAC15 gene enhances wood formation in transgenic tobacco

Over-expression of poplar NAC15 gene enhances wood formation in transgenic tobacco
11    79    0
Transcriptomic and physiological analysis of common duckweed Lemna minor responses to NH4 + toxicity

Transcriptomic and physiological analysis of common duckweed Lemna minor responses to NH4 + toxicity
13    64    0